DiagnostykaFRA:7JS +1.17%16 OCF Margin % is 20.57% as of Mar. 2026, which is 3% below its 10-year median of 21.30. GuruFocus rates FRA:7JS with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 204 Medical Diagnostics & Research companies, Diagnostyka ranks better than 81.37% on this metric.
The historical rank and industry rank for Diagnostyka's OCF Margin % or its related term are showing as below:
FRA:7JS'
s OCF Margin % Range Over the Past 10 Years
Min: 19.77 Med: 21.3 Max: 40.08
Current: 22.39
During the past 5 years, the highest OCF Margin % of Diagnostyka was 40.08%. The lowest was 19.77%. And the median was 21.30%.
FRA:7JS's OCF Margin % is ranked better than 81.37% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs FRA:7JS: 22.39
Diagnostyka OCF Margin % Related Terms
Diagnostyka OCF Margin % Historical Data
* Premium members only.
The historical data trend for Diagnostyka's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7JS vs TMO, DHR, IDXX: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Diagnostyka's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostyka OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diagnostyka's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Diagnostyka's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostyka (FRA:7JS) has a OCF Margin % of 20.57% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Diagnostyka and its competitors. This is near median its historical median of 21.30. Over the past decade, Diagnostyka's OCF Margin % has ranged from 19.77 to 40.08. According to the industry distribution chart, Diagnostyka ranks #38 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 18.6%.
Is Diagnostyka's OCF Margin % too high?
Diagnostyka's current OCF Margin % of 20.57% is near median its 10-year median of 21.30. Over the past 10 years, this metric has ranged from a low of 19.77 to a high of 40.08. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Diagnostyka's value of 20.57% is 332.6% above this industry median. Based on the distribution chart, Diagnostyka ranks #38 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Diagnostyka has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diagnostyka ranks #38 out of 204 companies for OCF Margin %. This places Diagnostyka in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.76. Diagnostyka's value of 20.57% is 332.6% above this benchmark. Historically, Diagnostyka's own OCF Margin % has ranged from 19.77 to 40.08 over the past decade. While the company's 10-year median is 21.30 vs. the industry median of 4.76, Diagnostyka has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostyka's current OCF Margin % of 20.57% is 332.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Diagnostyka and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostyka's current OCF Margin % is 20.57%, which is near median its own 10-year median of 21.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current OCF Margin % of 20.57%. The current OCF Margin % is 20.57%, which is near median its 10-year median of 21.30 and 332.6% above the Medical Diagnostics & Research industry median of 4.76. Diagnostyka's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current OCF Margin % is 20.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
16GF Score
Get the complete analysis for FRA:7JS
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JS has been successfully added to your 
